28 January 2021 - The Shimadzu-CGH Clinomics Centre (SC3) which will allow doctors to offer personalised treatment of patients with chronic diseases such as hypertension was officially opened on 27 January 2021.
The Centre uses technology called liquid chromatography coupled with tandem mass spectrometry that can accurately analyse clinical samples.
This will help doctors tailor more individualised treatment instead of taking a one-size-fits all approach.
SOURCE: LIANHE ZAOBAO SINGAPORE PRESS HOLDINGS LIMITED, REPRODUCED WITH PERMISSION
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.